Your browser doesn't support javascript.
loading
Assessment of 213Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-13C]pyruvate and [18F]FDG.
Feuerecker, Benedikt; Michalik, Michael; Hundshammer, Christian; Schwaiger, Markus; Bruchertseifer, Frank; Morgenstern, Alfred; Seidl, Christof.
Affiliation
  • Feuerecker B; Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Nuclear Medicine, Munich, Germany. benedikt.feuerecker@tum.de.
  • Michalik M; German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ), Heidelberg, Germany. benedikt.feuerecker@tum.de.
  • Hundshammer C; Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Nuclear Medicine, Munich, Germany.
  • Schwaiger M; Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Nuclear Medicine, Munich, Germany.
  • Bruchertseifer F; Department of Chemistry, Technical University of Munich, Garching, Germany.
  • Morgenstern A; Munich School of Bioengineering, Technical University of Munich, Garching, Germany.
  • Seidl C; Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Nuclear Medicine, Munich, Germany.
Sci Rep ; 9(1): 8294, 2019 06 05.
Article in En | MEDLINE | ID: mdl-31165773

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma / Urothelium / Pyruvic Acid / Fluorodeoxyglucose F18 / Antibodies, Monoclonal Limits: Humans Language: En Journal: Sci Rep Year: 2019 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma / Urothelium / Pyruvic Acid / Fluorodeoxyglucose F18 / Antibodies, Monoclonal Limits: Humans Language: En Journal: Sci Rep Year: 2019 Document type: Article Affiliation country: Germany Country of publication: United kingdom